Healthcare Analysts, along with Key Opinion Leader Dr. Sam Amin, discuss Tuberous Sclerosis Complex (TSC), (relevant companies JAZZ LBPH MRNS) on an Analyst/Industry conference call to be held on September 12 at 9 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations
- H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’
- Jazz Pharmaceuticals updates Phase 3 trial of cannabidiol oral solution
- Jazz Pharmaceuticals price target raised to $202 from $190 at JPMorgan
- Jazz Pharmaceuticals price target lowered to $154 from $160 at Baird